NCT00302406View on ClinicalTrials.gov

Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

methylphenidate hydrochloride

DRUG

OROS methylphenidate hydrochloride (CONCERTA)

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00302406 - Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate | Biotech Hunter | Biotech Hunter